New hepatitis C therapies approved in Europe
admin 31st July 2017 Uncategorised 0Patients with hepatitis C in Europe could soon gain access to two new pan-genotypic treatment options after the European Commission issued approval for AbbVie’s Maviret and Gilead’s Vosevi following an accelerated review.
More: New hepatitis C therapies approved in Europe
Source: News